Stock A102940 KOLON LIFE SCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Kolon Life Science Inc.

Equities

A102940

KR7102940004

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 14/05/2024 am IST 		5-day change 1st Jan Change
22,400 KRW +0.22% Intraday chart for Kolon Life Science Inc. +2.28% -12.84%
20/03 Kolon Life Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
05/03 Kolon Biotech, Inc. announced that it has received KRW 2.001 billion in funding from Kolon Life Science Inc. CI

Business Summary

KOLON LIFE SCIENCE Inc. is a Korea-based company mainly engaged in the manufacturing of functional materials. The Company operates its business under two segments. The Chemical Business segment produces and sells raw drug products, which are the raw materials of new drugs and generic drugs, antibacterial agents that suppress bacterial growth, water treatment agents for environmental purification, and functional material products for cosmetics. The Bio Business segment manufactures and sells bio new medicines based on cell gene therapy products.

Number of employees: 421

Sales per Business

KRW in Million2022Weight2023Weight Delta
Chemical
99.8 %
176,290 91.6 % 124,384 99.8 % -29.44%
Bio
0.2 %
16,112 8.4 % 255 0.2 % -98.42%

Sales per region

KRW in Million2022Weight2023Weight Delta
Japan
50.3 %
74,637 38.8 % 62,677 50.3 % -16.02%
Asia Pacific
22.6 %
52,571 27.3 % 28,147 22.6 % -46.46%
South Korea
13.3 %
46,095 24.0 % 16,545 13.3 % -64.11%
Others
8.0 %
8,162 4.2 % 9,991 8.0 % +22.41%
Europe
5.8 %
10,938 5.7 % 7,279 5.8 % -33.45%

Managers

Managers TitleAgeSince
Woo-Seok Lee CEO
 Chief Executive Officer 67 01/12/01
Ji-Yeon Han CMP
 Compliance Officer - -
Soo-Jeong Kim CTO
 Chief Tech/Sci/R&D Officer 56 -
Young-Wu Jo BRD
 Director/Board Member 57 01/16/01
Hyuk-Jin Kwon AUD
 Comptroller/Controller/Auditor 57 -

Members of the board

Members of the board TitleAgeSince
Woo-Seok Lee CEO
 Chief Executive Officer 67 01/12/01
Chan-Hee Lee BRD
 Director/Board Member 67 24/17/24
Young-Wu Jo BRD
 Director/Board Member 57 01/16/01
Soo-Jeong Kim CTO
 Chief Tech/Sci/R&D Officer 56 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,412,356 6,850,286 ( 60.03 %) 0 60.03 %

Shareholders

NameEquities%Valuation
KOLON CORPORATION
20.35 %
2,322,480 20.35 % 38 M ₩
Woong-Yeol Lee
18.87 %
2,153,127 18.87 % 35 M ₩
Chang-hee Seo
0.6116 %
69,796 0.6116 % 1 M ₩
Goldman Sachs Asset Management International
0.1857 %
21,192 0.1857 % 343 463 ₩
Kolon Life Science, Inc. Employee Stock Ownership Assn.
0.0370 %
4,218 0.0370 % 68 362 ₩
Pension Reserves Investment Management Board
0.0258 %
2,945 0.0258 % 47 730 ₩
Mirae Asset Global Investments Co., Ltd.
0.003566 %
407 0.003566 % 6 596 ₩
Goldman Sachs Asset Management (Singapore) Pte. Ltd.
0.003295 %
376 0.003295 % 6 094 ₩
DFA Australia Ltd.
0.000079 %
9 0.000079 % 146 ₩

Holdings

NameEquities%Valuation
KOLON TISSUEGENE, INC.
11.14%
 7,672,330 11.14% 67,169,638 $

Company contact information

KOLON LIFE SCIENCE, Inc.

110 Magokdong-ro Gangseo-gu

07793, Seoul

+

http://www.kolonls.co.kr
address Kolon Life Science Inc.(A102940)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
KOLON LIFE SCIENCE INC. Stock Kolon Life Science Inc.
-12.84% 19Cr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.37% 59TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 36TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+5.69% 29TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.83% 24TCr
NOVARTIS AG Stock Novartis AG
+9.93% 21TCr
ROCHE HOLDING AG Stock Roche Holding AG
-6.95% 20TCr
AMGEN INC. Stock Amgen Inc.
+10.77% 17TCr
PFIZER, INC. Stock Pfizer, Inc.
+0.10% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A102940 Stock
  4. Company Kolon Life Science Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW